Loading…
Lobbying Spend
—
Filings
13
Firms Hired
1
Active Period
2024–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Maintaining Investments in New Innovation Act
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1672
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 307
Improving Seniors’ Timely Access to Care Act of 2025
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3514
Gas Pipeline Leak Detection and Repair Act of 2025
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4818
Women’s Heart Health Expansion Act of 2026
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7417
Charting My Path for Future Success Act
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: S. 2407
Women’s Heart Health Expansion Act of 2026
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: S. 3944
Maintaining Investments in New Innovation Act
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1672
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 307
Improving Seniors’ Timely Access to Care Act of 2025
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3514
Gas Pipeline Leak Detection and Repair Act of 2025
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4818
Women’s Heart Health Expansion Act of 2026
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7417
Charting My Path for Future Success Act
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: S. 2407
Women’s Heart Health Expansion Act of 2026
2026 · third_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: — · Firm income: $30,000
Matched citations: S. 3944
Maintaining Investments in New Innovation Act
2026 · second_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1672
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 307
Gas Pipeline Leak Detection and Repair Act of 2025
2026 · second_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4818
Women’s Heart Health Expansion Act of 2026
2026 · second_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7417
Charting My Path for Future Success Act
2026 · second_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target.
Client expense: — · Firm income: $30,000
Matched citations: S. 2407
Women’s Heart Health Expansion Act of 2026
2026 · second_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target.
Client expense: — · Firm income: $30,000
Matched citations: S. 3944
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · first_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
Maintaining Investments in New Innovation Act
2026 · first_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1672
Full-Year Continuing Appropriations and Extensions Act, 2025
2026 · first_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1968
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 307
Gas Pipeline Leak Detection and Repair Act of 2025
2026 · first_quarter · Firm: VENABLE LLP
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4818
Source: Senate LDA